US Stock MarketDetailed Quotes

DCPH Deciphera Pharmaceuticals

Watchlist

25.280
+10.630+72.56%

Close Apr 29 16:00 ET

25.200
-0.080-0.32%

Post 19:45 ET

2.08BMarket Cap-11039P/E (TTM)

Deciphera Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

4.03%-146.7M

18.06%-28.81M

-43.11%-29.81M

15.15%-38.63M

3.69%-49.46M

36.53%-152.86M

47.66%-35.16M

61.43%-20.83M

12.40%-45.52M

24.13%-51.35M

Net income from continuing operations

-8.95%-194.94M

-2.73%-47.19M

-15.19%-49.58M

-12.77%-48.56M

-5.79%-49.61M

40.35%-178.93M

48.03%-45.94M

46.09%-43.04M

38.86%-43.06M

23.50%-46.89M

Depreciation and amortization

-28.72%2.1M

-24.13%456K

-37.33%465K

-30.37%571K

-22.35%608K

-2.26%2.95M

-22.95%601K

-2.24%742K

10.36%820K

6.97%783K

Other non cash items

8.46%4.48M

4.12%1.14M

3.98%1.12M

11.30%1.11M

15.51%1.1M

-44.59%4.13M

18.72%1.09M

-77.72%1.08M

18.76%1M

14.53%954K

Change In working capital

95.15%-1.54M

296.81%4.57M

4.87%9.05M

84.62%-2.65M

39.65%-12.5M

-3,959.51%-31.65M

-127.84%-2.32M

9.41%8.63M

-527.95%-17.24M

-6.62%-20.72M

-Change in receivables

-423.82%-9.35M

-438.78%-4.17M

-288.38%-4.49M

72.99%-766K

103.01%77K

73.37%-1.78M

148.31%1.23M

326.30%2.38M

-188.27%-2.84M

67.68%-2.56M

-Change in inventory

94.57%-386K

128.90%972K

11.56%3.53M

-151.63%-3.63M

76.99%-1.26M

30.00%-7.11M

51.12%-3.36M

259.25%3.17M

76.46%-1.44M

-377.14%-5.47M

-Change in prepaid assets

140.04%3.81M

118.81%2.17M

-3.10%3.9M

1,314.19%1.8M

-120.23%-4.06M

-19.86%-9.51M

-328.51%-11.54M

246.35%4.03M

-126.06%-148K

39.68%-1.84M

-Change in payables and accrued expense

224.41%12.62M

-6.30%11.36M

3,801.07%6.92M

106.81%813K

36.21%-6.47M

-136.07%-10.14M

-42.61%12.12M

-101.90%-187K

-270.64%-11.93M

-3.34%-10.15M

-Change in other current assets

-2,873.81%-5M

-493,400.00%-4.94M

--0

----

---168K

---1K

---7K

----

-Change in other current liabilities

-10.29%-3.24M

-8.65%-829K

-8.54%-813K

-11.53%-803K

-12.68%-791K

-16.89%-2.93M

-15.43%-763K

-19.65%-749K

-16.88%-720K

-15.65%-702K

Cash from discontinued investing activities

Operating cash flow

4.03%-146.7M

18.06%-28.81M

-43.11%-29.81M

15.15%-38.63M

3.69%-49.46M

36.53%-152.86M

47.66%-35.16M

61.43%-20.83M

12.40%-45.52M

24.13%-51.35M

Investing cash flow

Cash flow from continuing investing activities

136.58%12.55M

-86.51%2.2M

781.98%41.4M

104.19%4.36M

-159.37%-35.41M

-119.40%-34.31M

-83.52%16.3M

-142.04%-6.07M

-72.36%-104.19M

-51.86%59.65M

Net PPE purchase and sale

7.49%-778K

-431.58%-63K

89.18%-62K

-2.09%-293K

---360K

57.31%-841K

-98.29%19K

71.49%-573K

33.56%-287K

--0

Net intangibles purchase and sale

--0

----

--0

----

Net investment purchase and sale

139.82%13.33M

-86.11%2.26M

854.18%41.47M

104.48%4.65M

-158.76%-35.05M

-118.31%-33.47M

-83.36%16.29M

-126.88%-5.5M

-73.12%-103.91M

-52.10%59.65M

Cash from discontinued investing activities

Investing cash flow

136.58%12.55M

-86.51%2.2M

781.98%41.4M

104.19%4.36M

-159.37%-35.41M

-119.40%-34.31M

-83.52%16.3M

-142.04%-6.07M

-72.36%-104.19M

-51.86%59.65M

Financing cash flow

Cash flow from continuing financing activities

-7.87%152M

86.19%890K

7,359.33%15.59M

-99.49%838K

162,172.29%134.69M

1,008.09%164.99M

-75.83%478K

-87.75%209K

9,663.61%164.22M

-99.13%83K

Net common stock issuance

-8.57%149.75M

--0

--14.62M

--0

--135.13M

1,806.83%163.78M

--0

--163.78M

--0

Proceeds from stock option exercised by employees

76.17%2.89M

86.19%890K

363.16%968K

-3.79%838K

134.94%195K

-74.12%1.64M

-75.82%478K

-87.75%209K

-49.42%871K

-91.13%83K

Net other financing activities

-49.18%-634K

--0

---634K

-962.50%-425K

--0

----

Cash from discontinued financing activities

Financing cash flow

-7.87%152M

86.19%890K

7,359.33%15.59M

-99.49%838K

162,172.29%134.69M

1,008.09%164.99M

-75.83%478K

-87.75%209K

9,663.61%164.22M

-99.13%83K

Net cash flow

Beginning cash position

-25.64%64.74M

30.95%108.09M

-25.80%81.39M

20.25%114.64M

-25.64%64.74M

-35.93%87.06M

55.18%82.54M

20.62%109.7M

-52.72%95.33M

-35.93%87.06M

Current changes in cash

180.52%17.86M

-39.97%-25.72M

201.86%27.19M

-330.44%-33.43M

494.26%49.82M

54.82%-22.18M

-154.44%-18.38M

29.49%-26.69M

113.10%14.51M

-87.25%8.38M

Effect of exchange rate changes

727.59%910K

96.89%1.14M

-4.89%-493K

231.43%184K

169.30%79K

-157.54%-145K

382.50%579K

-600.00%-470K

-478.38%-140K

-11,500.00%-114K

End cash Position

28.99%83.51M

30.95%108.09M

-25.80%81.39M

20.25%114.64M

-25.64%64.74M

55.18%82.54M

20.62%109.7M

-52.72%95.33M

Free cash flow

4.05%-147.48M

17.83%-28.87M

-39.57%-29.87M

15.04%-38.92M

2.99%-49.82M

37.72%-153.7M

46.81%-35.14M

64.34%-21.4M

12.57%-45.81M

24.83%-51.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	4.03%-146.7M	18.06%-28.81M	-43.11%-29.81M	15.15%-38.63M	3.69%-49.46M	36.53%-152.86M	47.66%-35.16M	61.43%-20.83M	12.40%-45.52M	24.13%-51.35M
Net income from continuing operations	-8.95%-194.94M	-2.73%-47.19M	-15.19%-49.58M	-12.77%-48.56M	-5.79%-49.61M	40.35%-178.93M	48.03%-45.94M	46.09%-43.04M	38.86%-43.06M	23.50%-46.89M
Depreciation and amortization	-28.72%2.1M	-24.13%456K	-37.33%465K	-30.37%571K	-22.35%608K	-2.26%2.95M	-22.95%601K	-2.24%742K	10.36%820K	6.97%783K
Other non cash items	8.46%4.48M	4.12%1.14M	3.98%1.12M	11.30%1.11M	15.51%1.1M	-44.59%4.13M	18.72%1.09M	-77.72%1.08M	18.76%1M	14.53%954K
Change In working capital	95.15%-1.54M	296.81%4.57M	4.87%9.05M	84.62%-2.65M	39.65%-12.5M	-3,959.51%-31.65M	-127.84%-2.32M	9.41%8.63M	-527.95%-17.24M	-6.62%-20.72M
-Change in receivables	-423.82%-9.35M	-438.78%-4.17M	-288.38%-4.49M	72.99%-766K	103.01%77K	73.37%-1.78M	148.31%1.23M	326.30%2.38M	-188.27%-2.84M	67.68%-2.56M
-Change in inventory	94.57%-386K	128.90%972K	11.56%3.53M	-151.63%-3.63M	76.99%-1.26M	30.00%-7.11M	51.12%-3.36M	259.25%3.17M	76.46%-1.44M	-377.14%-5.47M
-Change in prepaid assets	140.04%3.81M	118.81%2.17M	-3.10%3.9M	1,314.19%1.8M	-120.23%-4.06M	-19.86%-9.51M	-328.51%-11.54M	246.35%4.03M	-126.06%-148K	39.68%-1.84M
-Change in payables and accrued expense	224.41%12.62M	-6.30%11.36M	3,801.07%6.92M	106.81%813K	36.21%-6.47M	-136.07%-10.14M	-42.61%12.12M	-101.90%-187K	-270.64%-11.93M	-3.34%-10.15M
-Change in other current assets	-2,873.81%-5M	-493,400.00%-4.94M	--0	----	----	---168K	---1K	---7K	----	----
-Change in other current liabilities	-10.29%-3.24M	-8.65%-829K	-8.54%-813K	-11.53%-803K	-12.68%-791K	-16.89%-2.93M	-15.43%-763K	-19.65%-749K	-16.88%-720K	-15.65%-702K
Cash from discontinued investing activities
Operating cash flow	4.03%-146.7M	18.06%-28.81M	-43.11%-29.81M	15.15%-38.63M	3.69%-49.46M	36.53%-152.86M	47.66%-35.16M	61.43%-20.83M	12.40%-45.52M	24.13%-51.35M
Investing cash flow
Cash flow from continuing investing activities	136.58%12.55M	-86.51%2.2M	781.98%41.4M	104.19%4.36M	-159.37%-35.41M	-119.40%-34.31M	-83.52%16.3M	-142.04%-6.07M	-72.36%-104.19M	-51.86%59.65M
Net PPE purchase and sale	7.49%-778K	-431.58%-63K	89.18%-62K	-2.09%-293K	---360K	57.31%-841K	-98.29%19K	71.49%-573K	33.56%-287K	--0
Net intangibles purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	139.82%13.33M	-86.11%2.26M	854.18%41.47M	104.48%4.65M	-158.76%-35.05M	-118.31%-33.47M	-83.36%16.29M	-126.88%-5.5M	-73.12%-103.91M	-52.10%59.65M
Cash from discontinued investing activities
Investing cash flow	136.58%12.55M	-86.51%2.2M	781.98%41.4M	104.19%4.36M	-159.37%-35.41M	-119.40%-34.31M	-83.52%16.3M	-142.04%-6.07M	-72.36%-104.19M	-51.86%59.65M
Financing cash flow
Cash flow from continuing financing activities	-7.87%152M	86.19%890K	7,359.33%15.59M	-99.49%838K	162,172.29%134.69M	1,008.09%164.99M	-75.83%478K	-87.75%209K	9,663.61%164.22M	-99.13%83K
Net common stock issuance	-8.57%149.75M	--0	--14.62M	--0	--135.13M	1,806.83%163.78M	--0	--0	--163.78M	--0
Proceeds from stock option exercised by employees	76.17%2.89M	86.19%890K	363.16%968K	-3.79%838K	134.94%195K	-74.12%1.64M	-75.82%478K	-87.75%209K	-49.42%871K	-91.13%83K
Net other financing activities	-49.18%-634K	--0	--0	--0	---634K	-962.50%-425K	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-7.87%152M	86.19%890K	7,359.33%15.59M	-99.49%838K	162,172.29%134.69M	1,008.09%164.99M	-75.83%478K	-87.75%209K	9,663.61%164.22M	-99.13%83K
Net cash flow
Beginning cash position	-25.64%64.74M	30.95%108.09M	-25.80%81.39M	20.25%114.64M	-25.64%64.74M	-35.93%87.06M	55.18%82.54M	20.62%109.7M	-52.72%95.33M	-35.93%87.06M
Current changes in cash	180.52%17.86M	-39.97%-25.72M	201.86%27.19M	-330.44%-33.43M	494.26%49.82M	54.82%-22.18M	-154.44%-18.38M	29.49%-26.69M	113.10%14.51M	-87.25%8.38M
Effect of exchange rate changes	727.59%910K	96.89%1.14M	-4.89%-493K	231.43%184K	169.30%79K	-157.54%-145K	382.50%579K	-600.00%-470K	-478.38%-140K	-11,500.00%-114K
End cash Position	28.99%83.51M	28.99%83.51M	30.95%108.09M	-25.80%81.39M	20.25%114.64M	-25.64%64.74M	-25.64%64.74M	55.18%82.54M	20.62%109.7M	-52.72%95.33M
Free cash flow	4.05%-147.48M	17.83%-28.87M	-39.57%-29.87M	15.04%-38.92M	2.99%-49.82M	37.72%-153.7M	46.81%-35.14M	64.34%-21.4M	12.57%-45.81M	24.83%-51.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall